BMGL

BASEL MED GROUP LTD

BMGL·G0864B111·US·Common Stock

BMGL institutional ownership changes in Q1 2026: 1 institution opened or added positions, 6 trimmed or exited. BMGL (BASEL MED GROUP LTD) is held by 2 institutional investors as of Q1 2026. Top institutional shareholders: XTX Topco Ltd ($15,660), UBS Group AG ($7,703). Net institutional sentiment: Bearish.

2
Holders
$23,363
Total Value
14% (7)
Consensus
1 buying - 6 selling
13F: Insider & Congress: Updated regularly
BMGL

Smart Money Verdict

View all
Loading verdict
Held by 2 funds

Who's Trading

Source dates: Price Nov 2, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for BMGL.

Top Holders

Checking access…
Action
Decreased
25,756(-15.4%)$15,6600.0%+869.23%
0
Increased
13,056(+61.4%)$7,7030.0%+360.06%
16
Exited
0(-100.0%)$7,1040.0%+9.62%
0
Exited
0(-100.0%)$00.0%+9.62%
0
Exited
0(-100.0%)$7,4920.0%+9.62%
0
Exited
0(-100.0%)$7,9810.0%+9.62%
0
Exited
0(-100.0%)$12,0890.0%-68.16%
0
BMGLBMGLBASEL MED GROUP LTD

Questions investors ask about BMGL

Who owns BMGL?

2 institutional investors held BMGL on March 31, 2026, led by XTX Topco Ltd ($15,660) and UBS Group AG ($7,703).

How many hedge funds hold BMGL?

2 institutional investors reported BMGL in their 13F filings for the quarter ended March 31, 2026, $23,363 in all.

Are institutions buying or selling BMGL?

Selling, on balance. In Q1 2026, 6 institutions trimmed or exited BMGL and 1 institution opened or added to a position.

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used